Finding an appropriate hs-cTnT cutoff in patients with severe CKD and suspected ACS who have undergone coronary angiography to objectify outcomes could help clarify the appropriate indication for cardiac catheterization and avoid further risks to these vulnerable patients. The gene discussed is TNNT2; the disease is chronic kidney disease.